As demonstrated by the pathway enrichment analysis, negative BL samples showed a higher fraction of Tumor Infiltrating Immune Cells (TIICs; absolute score mean of 1.82), similar to what was obtained for BRAF V600E positive samples (absolute score mean of 1.69). The gene discussed is BRAF; the disease is Burkitt lymphoma.